Research shows that most patients with advanced liver disease waiting for transplants have deficiencies in key vitamins and minerals, particularly selenium, vitamin B12, and vitamin E. A 2025 study of 275 transplant candidates found that patients lacking selenium were 2.55 times more likely to experience frailty, a condition where the body becomes weak and fragile. According to Gram Research analysis, selenium deficiency remained the strongest predictor of frailty even after accounting for disease severity and other health factors, suggesting that checking for and treating these nutrient gaps might help prevent weakness before transplant surgery.

A new study of 275 patients with advanced liver disease found that most are missing important vitamins and minerals their bodies need. Researchers discovered that patients lacking selenium, vitamin B12, and vitamin E were more likely to experience frailty, a condition where the body becomes weak and fragile. According to Gram Research analysis, selenium deficiency was the strongest predictor of frailty in these patients. These findings suggest that checking for and treating these nutrient gaps might help patients feel stronger before receiving a liver transplant, though more research is needed to confirm this approach works.

Key Statistics

A 2025 study of 275 ambulatory patients with cirrhosis awaiting liver transplant found that 34% of frail patients had vitamin B12 deficiency compared to 18% of non-frail patients, a statistically significant difference.

Among 275 liver disease patients waiting for transplant, those with selenium deficiency had 2.55 times increased odds of frailty after controlling for disease severity and other health factors, according to research published in Hepatology Communications in 2025.

A 2025 analysis of 275 transplant candidates found that 28% of frail patients had selenium deficiency compared to 13% of non-frail patients, with selenium deficiency being the only nutrient deficiency independently associated with frailty after multivariate analysis.

Micronutrient deficiencies in zinc, vitamin D, vitamin E, vitamin B12, and selenium were common in a 2025 study of 275 ambulatory adults with cirrhosis, with researchers recommending routine screening for these nutrients in transplant candidates.

The Quick Take

  • What they studied: Whether patients with severe liver disease waiting for transplants have missing vitamins and minerals, and if these deficiencies make them weaker and more fragile.
  • Who participated: 275 adults with cirrhosis (scarring of the liver) who were waiting for liver transplants. The average age was 60 years old, and 42% were women. About 23% of the group showed signs of frailty, meaning their bodies were weak and they tired easily.
  • Key finding: Most patients had deficiencies in zinc, vitamin D, vitamin E, vitamin B12, and selenium. Patients missing selenium were 2.55 times more likely to be frail after accounting for other health factors. Frail patients were twice as likely to lack vitamin B12 and vitamin E compared to stronger patients.
  • What it means for you: If you or a loved one has advanced liver disease and is waiting for a transplant, doctors may want to test for these specific nutrient deficiencies. Treating these gaps could potentially help prevent weakness and frailty before transplant surgery. However, this is still early research, and more studies are needed to prove that adding these nutrients actually helps.

The Research Details

Researchers studied 275 adults with cirrhosis who were waiting for liver transplants between June 2024 and March 2025. They tested all patients for deficiencies in key vitamins and minerals including zinc, vitamin A, vitamin D, vitamin E, vitamin B12, and selenium. They also assessed which patients showed signs of frailty, a medical condition where the body becomes weak, muscles shrink, and people tire easily.

The researchers used statistical analysis to look for connections between missing nutrients and frailty. They first looked at simple relationships between each nutrient and frailty. Then they used more advanced analysis to control for other health factors that might affect the results, such as liver disease severity and age. This helps ensure that the nutrient deficiencies themselves, not other health problems, were causing the frailty.

This type of study is called a cross-sectional analysis because researchers looked at all patients at one point in time rather than following them over months or years. This approach is useful for identifying patterns and connections but cannot prove that fixing nutrient deficiencies will actually prevent frailty.

Patients with severe liver disease often have trouble absorbing and storing nutrients because their livers cannot function properly. Understanding which nutrients are most commonly missing helps doctors know what to test for and potentially treat. By identifying frailty early and connecting it to specific nutrient gaps, doctors may be able to intervene before patients become too weak for surgery. This research provides a practical roadmap for which nutrients doctors should routinely check in this patient population.

This study has several strengths: it included a reasonable number of patients (275), used standardized medical tests to measure nutrient levels, and applied rigorous statistical methods to control for confounding factors. The study was conducted in real clinical practice rather than a controlled lab setting, making results more applicable to everyday patient care. However, the study was conducted at a single time point, so we cannot determine whether treating these deficiencies actually improves outcomes. The findings need confirmation in future studies that follow patients over time and test whether nutrient supplementation reduces frailty.

What the Results Show

Micronutrient deficiencies were extremely common in this group of liver disease patients. Zinc deficiency was present in a large portion of patients, and deficiencies in vitamin D, vitamin E, vitamin B12, and selenium were also widespread. When researchers compared frail patients to non-frail patients, they found striking differences in nutrient status.

Patients who were frail had much higher rates of specific nutrient deficiencies. For vitamin B12, 34% of frail patients were deficient compared to only 18% of non-frail patients. For vitamin E, the numbers were 36% versus 20%. For selenium, 28% of frail patients were deficient compared to 13% of non-frail patients. These differences were statistically significant, meaning they were unlikely to occur by chance.

When looking at the strength of these associations, selenium deficiency stood out as the strongest predictor of frailty. Patients with selenium deficiency had 3 times the odds of being frail in initial analysis. Even after accounting for other health factors like disease severity and age, selenium deficiency remained independently linked to frailty with 2.55 times increased odds. Vitamin B12 and vitamin E deficiencies also showed associations with frailty in initial analysis, but these connections weakened when other factors were controlled for.

The study identified zinc and vitamin A deficiencies as common problems in this patient population, though these were not specifically linked to frailty in the analysis. Vitamin D deficiency was also prevalent. The researchers suggest that checking for all of these nutrients may be practical in clinical care because they tend to occur together in patients with advanced liver disease. The median MELD 3.0 score (a measure of liver disease severity) was 17, indicating moderately advanced disease in most patients.

Previous research has established that micronutrient deficiencies occur in patients with cirrhosis, but most prior studies focused on hospitalized patients with severe disease. This study is novel because it specifically examines ambulatory patients who are stable enough to be waiting at home for transplants. The connection between selenium deficiency and frailty is particularly important because frailty has been identified in recent years as a major risk factor for poor outcomes after transplant surgery. This research builds on growing evidence that frailty is a modifiable condition that might be improved through nutritional intervention.

This study has important limitations that readers should understand. First, it was conducted at a single point in time, so researchers cannot prove that nutrient deficiencies cause frailty or that treating them will improve outcomes. Second, the study was observational, meaning researchers simply measured what was already happening rather than randomly assigning patients to receive treatment. This makes it impossible to rule out that some other unmeasured factor is causing both the nutrient deficiency and the frailty. Third, the study was conducted at a single medical center, so results may not apply to all liver disease patients in all settings. Finally, the study did not measure how long patients had been deficient or whether they had received any prior nutritional support, which could affect the results.

The Bottom Line

For patients with advanced liver disease awaiting transplant: Ask your doctor to test you for deficiencies in selenium, vitamin B12, vitamin E, zinc, vitamin A, and vitamin D. If deficiencies are found, discuss with your doctor whether supplementation is appropriate for your situation. These recommendations are based on observational research showing associations between deficiencies and frailty, not yet on proven treatments. Confidence level: Moderate. The evidence strongly suggests these nutrients should be measured, but we need more research to confirm that supplementation improves outcomes.

This research is most relevant to adults with cirrhosis who are waiting for liver transplants. It may also apply to patients with advanced liver disease who are not yet transplant candidates. The findings are less relevant to people with mild liver disease or those without liver problems. Healthcare providers caring for transplant candidates should pay special attention to these findings and consider routine micronutrient screening.

If nutrient deficiencies are treated, improvements in strength and frailty would likely take weeks to months to become apparent, similar to how nutritional interventions work in other patient populations. However, this timeline is based on general nutritional science, not on specific studies in liver disease patients. Patients should not expect immediate changes and should work closely with their medical team to monitor progress.

Frequently Asked Questions

What nutrients are most commonly missing in people with liver disease?

A 2025 study of 275 liver disease patients found that zinc, vitamin D, vitamin E, vitamin B12, and selenium deficiencies were especially common. Selenium deficiency was most strongly linked to frailty, a condition where the body becomes weak and tired easily.

Can nutrient deficiencies make liver disease patients weaker?

Research suggests a connection: patients with selenium, vitamin B12, or vitamin E deficiency were significantly more likely to experience frailty. However, this study shows association, not proof that the deficiency causes weakness. More research is needed to confirm that treating these deficiencies improves strength.

Should I get tested for nutrient deficiencies if I have cirrhosis?

If you have advanced liver disease and are waiting for a transplant, discussing nutrient testing with your doctor is reasonable based on this research. A 2025 study suggests checking for zinc, vitamin D, vitamin E, vitamin B12, and selenium as a practical screening panel in clinical practice.

How long does it take to fix nutrient deficiencies?

Nutrient repletion typically takes weeks to months depending on the severity of deficiency and the nutrient involved. This study did not measure how long treatment takes, but general nutritional science suggests patience is needed to see improvements in strength and frailty.

Is this study proof that supplements will help me before transplant?

No, this study shows that nutrient deficiencies are common and linked to frailty, but it does not prove that supplements will help. More research testing actual supplementation is needed. Discuss with your transplant team whether supplementation is appropriate for your situation.

Want to Apply This Research?

  • Track your energy levels and physical function daily using a simple 1-10 scale. Note any changes in ability to walk, climb stairs, or perform daily activities. If you receive nutrient supplementation, compare your baseline scores to scores after 4, 8, and 12 weeks to monitor for improvement.
  • If your doctor prescribes nutrient supplements, set daily reminders to take them at the same time each day. Log each dose in the app to ensure consistency. Consistency is critical for nutrient repletion to work effectively.
  • Schedule follow-up nutrient testing with your doctor every 3 months while awaiting transplant. Track test results in the app to visualize whether nutrient levels are improving with supplementation. Also monitor frailty-related measures like walking speed or grip strength if your doctor assesses these, as improvements in these measures would indicate the intervention is working.

This article summarizes research findings and should not be interpreted as medical advice. Patients with cirrhosis or advanced liver disease should not start, stop, or change nutrient supplementation without consulting their healthcare provider. Nutrient deficiencies can have multiple causes and may require individualized treatment. The findings in this study show associations between nutrient deficiencies and frailty but do not prove that supplementation will prevent or reverse frailty. All treatment decisions should be made in consultation with your transplant team or hepatologist who understands your complete medical situation.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Micronutrient deficiencies in ambulatory adults with cirrhosis. , Hepatology communications (2026). PubMed 42579771 | DOI
Topics
liver disease micronutrients cirrhosis nutrient deficiency selenium deficiency frailty liver transplant nutrition vitamin B12 liver disease frailty cirrhosis micronutrient screening transplant candidate health